BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 8519690)

  • 1. Protein kinase C-dependent and -independent pathways of signal transduction in prostate cancer cells: fibroblast growth factor utilization of a protein kinase C-independent pathway.
    Hrzenjak M; Shain SA
    Cell Growth Differ; 1995 Sep; 6(9):1129-42. PubMed ID: 8519690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction defect appears to be the cause of rat prostate cancer cell fibroblast growth factor insensitivity.
    Shain SA; Lin AL; Wong G
    Cell Growth Differ; 1992 Oct; 3(10):715-22. PubMed ID: 1445801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways.
    Hrzenjak M; Shain SA
    Recept Signal Transduct; 1997; 7(4):207-19. PubMed ID: 9633822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in responsiveness of clonally derived AXC/SSh rat prostate cancer cells to secreted or prototypic mitogens.
    Shain SA; Koger JD
    Cancer Res; 1989 Jul; 49(14):3898-903. PubMed ID: 2786746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction by basic fibroblast growth factor in rat osteoblastic Py1a cells.
    Hurley MM; Marcello K; Abreu C; Kessler M
    J Bone Miner Res; 1996 Sep; 11(9):1256-63. PubMed ID: 8864900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
    Arita Y; Buffolino P; Coppock DL
    Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of human melanocyte cultures supported by 12-O-tetradecanoylphorbol-13-acetate is mediated through protein kinase C activation.
    Arita Y; O'Driscoll KR; Weinstein IB
    Cancer Res; 1992 Aug; 52(16):4514-21. PubMed ID: 1643643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
    Jalava A; Akerman K; Heikkilä J
    J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C isoform delta is involved in the stimulation of the Na(+)-H+ exchanger in C6 glioma cells.
    Chen CC; Wu ML
    Mol Pharmacol; 1995 Dec; 48(6):995-1003. PubMed ID: 8848016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells.
    Yu SM; Chen SF; Lau YT; Yang CM; Chen JC
    Mol Pharmacol; 1996 Oct; 50(4):1000-9. PubMed ID: 8863847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP; Buckley DJ; Buckley AR
    Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered function of protein kinase C and cyclic adenosine monophosphate-dependent protein kinase in a cell line derived from a mouse lung papillary tumor.
    Nicks KM; Droms KA; Fossli T; Smith GJ; Malkinson AM
    Cancer Res; 1989 Sep; 49(18):5191-8. PubMed ID: 2548715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role for G proteins in prostate cancer cell growth and signaling.
    Kue PF; Daaka Y
    J Urol; 2000 Dec; 164(6):2162-7. PubMed ID: 11061948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells.
    Greco S; Muscella A; Elia MG; Romano S; Storelli C; Marsigliante S
    J Cell Physiol; 2004 Oct; 201(1):84-96. PubMed ID: 15281091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat prostate cancer cell line-specific production and apparent secretion of heparin-binding growth factors.
    Shain SA; Ke LD; Wong G; Karaganis AG
    Cell Growth Differ; 1992 Apr; 3(4):249-58. PubMed ID: 1381214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ornithine decarboxylase mRNA by phorbol esters and insulin in normal and C-kinase-deficient rat hepatoma cells.
    Butler AP; Cohn WB; Mar PK; Montgomery RL
    J Cell Physiol; 1991 May; 147(2):256-64. PubMed ID: 2040659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat prostate cancer cells contain functional receptors for transforming growth factor-beta.
    Shain SA; Lin AL; Koger JD; Karaganis AG
    Endocrinology; 1990 Feb; 126(2):818-25. PubMed ID: 2153528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF signaling activates STAT1 and p21 and inhibits the estrogen response and proliferation of MCF-7 cells.
    Johnson MR; Valentine C; Basilico C; Mansukhani A
    Oncogene; 1998 May; 16(20):2647-56. PubMed ID: 9632141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.